SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001714899-19-000017
Filing Date
2019-03-12
Accepted
2019-03-12 21:09:30
Documents
3
Effectiveness Date
2019-03-12

Document Format Files

Seq Description Document Type Size
1 S-8 forms-831219.htm S-8 134674
2 EXHIBIT 5.1 exhibit5131219.htm EX-5.1 7423
3 EXHIBIT 23.1 exhibit23131219.htm EX-23.1 2794
  Complete submission text file 0001714899-19-000017.txt   145951
Mailing Address 151 OYSTER POINT BLVD. 2ND FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address 151 OYSTER POINT BLVD. 2ND FLOOR SOUTH SAN FRANCISCO CA 94080 (650) 866-8548
Denali Therapeutics Inc. (Filer) CIK: 0001714899 (see all company filings)

IRS No.: 463872213 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-230223 | Film No.: 19676945
SIC: 2836 Biological Products, (No Diagnostic Substances)